AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+15.01%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.22B
AUM Growth
+$1.22B
(+33%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
10.74%
Top 10 Holdings %
Top 10 Hldgs %
43.34%
Holding
94
New
24
Increased
23
Reduced
14
Closed
27
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$55.8M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$53.2M |
| 3 |
Pacira BioSciences
PCRX
|
$40.8M |
| 4 |
Biogen
BIIB
|
$35.5M |
| 5 |
Burlington
BURL
|
$31.3M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$72.9M |
| 2 |
SGI
Somnigroup International Inc.
SGI
|
$34.1M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$31.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$26.1M |
| 5 |
Voyager Therapeutics
VYGR
|
$24.9M |
Sector Composition
| 1 | Healthcare | 53.85% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Consumer Staples | 10.23% |
| 4 | Industrials | 7.48% |
| 5 | Communication Services | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $107M | 5.85% | 18,304,285 +175,486 | +1% | +$1.02M |
|
2
Energizer
ENR
$1.88B
| $58.2M | 3.19% | 1,296,000 +228,000 | +21% | +$10.2M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $55.8M | 3.06% | +592,000 | New | +$55.8M |
|
|
4
Madrigal Pharmaceuticals
MDGL
$9.76B
| $53.2M | 2.91% | +425,000 | New | +$53.2M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $52.1M | 2.85% | 2,100,000 -2,936,000 | -58% | -$72.9M |
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $42.7M | 2.34% | 3,316,000 +1,438,000 | +77% | +$18.5M |
|
7
Edgewell Personal Care
EPC
$1.12B
| $42.7M | 2.34% | 972,000 -48,000 | -5% | -$2.11M |
|
|
8
Pacira BioSciences
PCRX
$1.2B
| $40.8M | 2.23% | +1,072,000 | New | +$40.8M |
|
9
Frontdoor
FTDR
$4.43B
| $39M | 2.13% | 1,132,000 +532,000 | +89% | +$18.3M |
|
|
DFRG
10
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $35.9M | 1.96% | 5,600,000 +1,072,000 | +24% | +$6.87M |
|
11
Enanta Pharmaceuticals
ENTA
$180M
| $35.5M | 1.94% | 372,000 -128,000 | -26% | -$12.2M |
|
|
12
Biogen
BIIB
$19.4B
| $35.5M | 1.94% | +150,000 | New | +$35.5M |
|
|
WBT
13
DELISTED
Welbilt, Inc.
WBT
| $32.8M | 1.79% | 2,000,000 +242,000 | +14% | +$3.96M |
|
|
MNK
14
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $32.6M | 1.78% | 1,500,000 -800,000 | -35% | -$17.4M |
|
15
Target
TGT
$43.6B
| $32.1M | 1.76% | 400,000 +300,000 | +300% | +$24.1M |
|
|
16
Burlington
BURL
$18.3B
| $31.3M | 1.72% | +200,000 | New | +$31.3M |
|
|
ATRS
17
DELISTED
Antares Pharma, Inc.
ATRS
| $31.2M | 1.71% | 10,300,000 | – | – |
|
|
18
Voyager Therapeutics
VYGR
$186M
| $29.4M | 1.61% | 1,536,000 -1,300,000 | -46% | -$24.9M |
|
19
AutoZone
AZO
$70.2B
| $28.7M | 1.57% | 28,000 +12,000 | +75% | +$12.3M |
|
|
PLYA
20
DELISTED
Playa Hotels & Resorts
PLYA
| $27.3M | 1.5% | 3,580,000 -2,092,000 | -37% | -$16M |
|
21
Assembly Biosciences
ASMB
$190M
| $22.2M | 1.22% | 1,128,000 +1,028,000 | +1,028% | +$20.2M |
|
22
Home Depot
HD
$405B
| $21.5M | 1.18% | +112,000 | New | +$21.5M |
|
|
SPPI
23
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $20.6M | 1.13% | 1,928,000 +428,000 | +29% | +$4.58M |
|
|
ADMS
24
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $19.5M | 1.07% | 2,744,000 +2,086,000 | +317% | +$14.8M |
|
|
DPLO
25
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $17.4M | 0.95% | +3,000,000 | New | +$17.4M |
|